The relationship of reported HIV risk and history of HIV testing among emergency department patients

Postgraduate Medicine

Volumn 122, Issue 1, 2010, Pages 61-74

  Merchant, Roland C ^a   Freelove, Sarah M ^a   Langan IV, Thomas J ^a   Clark, Melissa A ^a   Mayer, Kenneth H ^a   Seage III, George R ^b   DeGruttola, Victor G ^b  

^a BROWN UNIVERSITY   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Emergency medicine; HIV; Sexually transmitted diseases

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; CONTROLLED STUDY; DRUG USE; EMERGENCY WARD; FEMALE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RISK ASSESSMENT; SEX DIFFERENCE;

ADOLESCENT; ADULT; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEALTH STATUS INDICATORS; HEALTH SURVEYS; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; NEW ENGLAND; ODDS RATIO; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; RISK FACTORS; URBAN POPULATION; YOUNG ADULT;

EID: 76249103641     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2010.01.2100     Document Type: Article

References (24)

1. Branson B, Handsfield HH, Lampe MA, et al; Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-l4): 1-17.
2. Merchant RC, Catanzaro BM, Seage GR 3rd, DeGruttola VG, Becker BM. Demographic variations in HIV testing history among emergency department patients: implications for HIV screening in U.S. emergency departments. J Med Screen. 2009;16(2):60-66.
3. Merchant RC, Seage GR 3rd, Mayer KH, Clark MA, DeGruttola VG, Becker BM. Emergency department patient acceptance of opt-in, universal, rapid HIV screening. Public Health Rep. 2008;123(suppl 3): 27-40.
4. Provisional Public Health Service inter-agency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep. 1985;34(1):1-5.
5. Centers for Disease Control and Prevention. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace. MMWR Morb Mortal Wkly Rep. l985;34(45):681-686, 691-685.
6. Centers for Disease Control (CDC). Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus. MMWR Morh Mortal Wkly Rep. 1986;35(10):152-155.
7. Centers for Disease Control (CDC). Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. MMWR Morb Mortal Wkly Rep. 1987;36(31):509-515.
8. Recommendations for HIV testing services for inpatients and outpatients in acute-care hospital settings. Center for Disease Control and Prevention. MMWR Recomm Rep. 1993;42(RR-2):1-6.
9. U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR Recomm Rep. 1995;44(RR-7):1-15.
10. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral. MMWR Recomm Rep. 2001; 50(RR-19):1-57.
11. Anderson JE, Chandra A, Mosher WD. HIV testing in the United States, 2002. Adv Data. 2005;(363):1-32.
12. Anderson JE, Carey JW, Taveras S. HIV testing among the general U.S. population and persons at increased risk: information from national surveys, 1987-1996. Am J Public Health. 2000;90(7):1089-1095.
13. Anderson JE, Mosher WD, Chandra A. Measuring HIV risk in the U.S. population aged 15-44: results from Cycle 6 of the National Survey of Family Growth. Adv Data. 2006(377):1-27.
14. Anderson JE, Santelli J, Mugalla C. Changes in HIV-related preventive behavior in the U.S. population: data from national surveys, 1987-2002. J Acquir Immune Defic Syndr. 2003;34(2):195-202.
15. Holtzman D, Bland SD, Lansky A, Mack KA. HIV-related behaviors and perceptions among adults in 25 states: 1997 Behavioral Risk Factor Surveillance System. Am J Public Health. 2001:91(11):1882-1888.
16. Persons tested for HIV - United States, 2006. MMWR Morb Mortal Wkly Rep. 2008;57(31):845-849.
17. Merchant R, Gee E, Clark M, Mayer K, Seage GI 3rd, DeGruttola V. Comparison of patient comprehension of rapid HIV pre-test fundamentals by information delivery format in an emergency department setting. BMC Public Health. 2007;7:238.
18. Merchant RC, Clark MA, Langan TJ 4th, Seage GR 3rd, Mayer KH, DeGruttola VG. Effectiveness of increasing emergency department patients' self-perceived risk for being Human Immunodeficiency Virus (HIV)-infected through audio computer self interview - based feedback about reported HIV risk behaviors. Acad Emerg Med. 2009;16(11): 1143-1155.
19. The AIDS incubation period in the UK estimated from a national register of HIV seroconverters. UK Register of HIV Seroconverters Steering Committee. AIDS. 1998:12(6):659-667.
20. Bailey NT. A revised assessment of the HIV/AIDS incubation period, assuming a very short early period of high infectivity and using only San Francisco public health data on prevalence and incidence. Stat Med. 1997;16(21):2447-2458.
21. Chevret S. Costagliola D, Lefrere JJ, Valleron AJ. A new approach to estimating AIDS incubation times: results in homosexual infected men. J Epidemiol Community health. 1992;46(6):582-586.
22. Bacchetti P, Moss AR. Incubation period of AIDS in San Francisco. Nature. 1989;338(6212):251-253.
23. Tassie JM, Grabar S, Lancar R, Deloumeaux J, Bentata M, Costagliola D; Clinical Epidemiology Group from the French Hospital Database on HIV. Time to AIDS from 1992 to 1999 in HIV-1-infected subjects with known date of infection. J Acquir Immune Defic Syndr. 2002;30(1): 81-87.
24. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on Sero-Conversion to AIDS and Death in Europe. Lancet. 2000;355(9210): 1131-1137.